To demonstrate whether the effect of sirt5 inhibition on tumor growth is through PKM2 K498 succinylation, we carried out rescue experiments by treating previously described A549 stable cell lines expressing PKM2 wild type or K498E mutant (Figure 4A) with SIRT5 inhibitor Suramin. Here, PKM is linked to neoplasm.